Literature DB >> 7852923

Microalbuminuria, insulin sensitivity and haemostatic factors in non-diabetic treated hypertensive men. Risk Factor Intervention Study Group.

S Agewall1, B Fagerberg, S Attvall, S Ljungman, V Urbanavicius, L Tengborn, J Wikstrand.   

Abstract

OBJECTIVE: To examine whether microalbuminuria in non-diabetic, treated hypertensive men is associated with insulin resistance and measures of endothelial function, thrombogenesis and fibrinolysis.
DESIGN: Cross-sectional study.
SETTING: Outpatient clinic in city hospital. PATIENTS: Ninety-two treated hypertensive men, aged 57-77 years, either with a serum cholesterol of > or = 6.5 mmol L-1 or smokers, or both. Patients with diabetes mellitus or overnight urinary albumin excretion of > 100 mg 12 h-1 were excluded. MAIN OUTCOME MEASURES: Overnight urinary albumin excretion, insulin-mediated glucose disposal (hyperinsulinaemic euglycaemic clamp), blood glucose and plasma insulin during oral glucose tolerance test, fibrinogen, von Willebrand factor and plasminogen activator inhibitor activity.
RESULTS: Microalbuminuric patients had increased blood glucose concentrations during the oral glucose tolerance test and higher plasma fibrinogen levels compared with the normoalbuminuric patients. In a randomly selected subgroup (n = 36), insulin-mediated glucose disposal was lower in microalbuminuric than in normoalbuminuric patients, and an inverse relationship between insulin sensitivity and albuminuria (r = -0.37; P = 0.028) was found. This relationship was not significant after adjustment for body-mass index (P = 0.098). In the univariate analyses including all patients, albuminuria was associated with blood glucose, serum creatinine, body-mass index, systolic blood pressure, fibrinogen, von Willebrand factor and cholesterol (negatively). In a multiple regression analysis, only the body-mass index was independently related to urinary albumin excretion.
CONCLUSIONS: Microalbuminuria was associated with insulin resistance but obesity was a confounding factor. Relationships between microalbuminuria and fibrinogen as well as von Willebrand factor were found, but only in univariate analysis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7852923     DOI: 10.1111/j.1365-2796.1995.tb01161.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  10 in total

1.  Proteinuria and metabolic syndrome as predictors of cardiovascular death in non-diabetic and type 2 diabetic men and women.

Authors:  A Juutilainen; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  Diabetologia       Date:  2005-12-20       Impact factor: 10.122

Review 2.  Treatment of patients with essential hypertension and microalbuminuria.

Authors:  J Redon
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

3.  Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation.

Authors:  Dimitrios Daoussis; Vasileios F Panoulas; Holly John; Tracey E Toms; Ioannis Antonopoulos; Gareth Treharne; Peter Nightingale; Karen M J Douglas; George D Kitas
Journal:  Clin Rheumatol       Date:  2010-04-16       Impact factor: 2.980

4.  Prior gestational hyperglycemia: a long-term predictor of the metabolic syndrome.

Authors:  S Bo; L Monge; C Macchetta; G Menato; S Pinach; B Uberti; G Pagano
Journal:  J Endocrinol Invest       Date:  2004 Jul-Aug       Impact factor: 4.256

Review 5.  Development of microalbuminuria in essential hypertension.

Authors:  Josep Redon; Jose M Pascual
Journal:  Curr Hypertens Rep       Date:  2006-05       Impact factor: 5.369

6.  Association of D-dimer with microalbuminuria in patients with type 2 diabetes mellitus.

Authors:  Ichiro Wakabayashi; Hiroshi Masuda
Journal:  J Thromb Thrombolysis       Date:  2007-10-11       Impact factor: 2.300

7.  Association of insulin resistance with chronic kidney disease in non-diabetic subjects with normal weight.

Authors:  Shanying Chen; Youming Chen; Xinyu Liu; Mi Li; Bide Wu; Yongqiang Li; Yan Liang; Xiaofei Shao; Harry Holthöfer; Hequn Zou
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

8.  Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients.

Authors:  Thomas W Jax; Ansgar J Peters; Gunnar Plehn; Frank-Chris Schoebel
Journal:  Cardiovasc Diabetol       Date:  2009-09-07       Impact factor: 9.951

9.  Relevance of hemostatic risk factors on coronary morphology in patients with diabetes mellitus type 2.

Authors:  Thomas W Jax; Ansgar J Peters; Gunnar Plehn; Frank-Chris Schoebel
Journal:  Cardiovasc Diabetol       Date:  2009-05-06       Impact factor: 9.951

10.  Insulin resistance is associated with urinary albumin-creatinine ratio in normal weight individuals with hypertension and diabetes: The REACTION study.

Authors:  Shi Gu; Anping Wang; Guang Ning; Linxi Zhang; Yiming Mu
Journal:  J Diabetes       Date:  2020-01-10       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.